investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Molecular Signatures of Lethal and Indolent Prostate Cancer
Mark A Rubin
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mark A Rubin
Weill Cornell Medical College
New York, United States
Francesca Demichelis
University of Trento
Trento, Italy
Related projects
Clare M Tempany
Enabling Technologies For MRI-Guided Prostate Interventions
Prostate
Pathology
Baowei Fei
Molecular Imaging Directed, 3D Ultrasound-guided, Biopsy System
Prostate
Pathology
Cory Abate-Shen
Preclinical Analyses of Advanced Prostate Cancer in Genetically-Engineered Mice
Prostate
Pathology
Kathryn M Wilson
Bone Metabolism and Bone Metastases in Prostate Cancer
Prostate
Pathology
Patricia Jean Johnson
Trichomonas vaginalis exosomes: Mediators of host:pathogen interactions
Prostate
Pathology
Stephen N Thibodeau
Prostate Cancer Susceptibility: The ICPCG Study
Prostate
Pathology
Clare M Tempany
Enabling Technologies for MRI-Guided Prostate Interventions
Prostate
Pathology
Hui Zhang
Glycoprotein Biomarkers for the Early Detection of Aggressive Prostate Cancer
Prostate
Pathology
Rosalynd Denise Upton
Elucidating the Molecular Basis of Metastatic Prostate Cancer Cell Progression
Prostate
Pathology